Insider Selling: Louis Calvarin Sells 2,000 Shares of Innophos Holdings Stock (IPHS)
Innophos Holdings (NASDAQ:IPHS) VP Louis Calvarin sold 2,000 shares of the stock on the open market in a transaction dated Monday, September 16th. The stock was sold at an average price of $50.91, for a total value of $101,820.00. Following the completion of the transaction, the vice president now directly owns 65,073 shares of the company’s stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Separately, analysts at Zacks upgraded shares of Innophos Holdings (NASDAQ:IPHS) from an “underperform” rating to a “neutral” rating in a research note to investors on Tuesday, July 2nd. They now have a $48.80 price target on the stock.
Shares of Innophos Holdings (NASDAQ:IPHS) traded up 1.29% on Wednesday, hitting $51.91. The stock had a trading volume of 44,361 shares. Innophos Holdings has a one year low of $43.29 and a one year high of $55.60. The stock has a 50-day moving average of $50.36 and a 200-day moving average of $51.3. The company has a market cap of $1.140 billion and a price-to-earnings ratio of 21.15.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings data on Monday, July 29th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.01. The company had revenue of $213.18 million for the quarter, compared to the consensus estimate of $227.35 million. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company’s revenue for the quarter was down .5% on a year-over-year basis. Analysts expect that Innophos Holdings will post $3.06 EPS for the current fiscal year.
Innophos Holdings, Inc (NASDAQ:IPHS), is a producer of mineral-based specialty ingredients with applications in food, beverage, pharmaceutical, oral care and industrial end markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.